Next Article in Journal
Extract of the Blood Circulation-Promoting Recipe-84 Can Protect Rat Retinas by Inhibiting the β-Catenin Signaling Pathway
Next Article in Special Issue
Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response
Previous Article in Journal
Leukocyte Immunoglobulin-Like Receptors A2 and A6 are Expressed in Avian Macrophages and Modulate Cytokine Production by Activating Multiple Signaling Pathways
Previous Article in Special Issue
HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer

Laboratorio de Genómica, Instituto Nacional de Cancerología (INCan), Av. San Fernando 22, Col. Sección XVI, Tlalpan, C.P. 14080 Ciudad de México, Mexico
Unidad de Biomedicina, FES-IZTACALA, Universidad Nacional Autónoma de México (UNAM), Av. De Los Barrios 1. Col. Los Reyes Iztacala, C.P. 54090 Tlalnepantla, Mexico
Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, San Lorenzo 290, Del Valle Sur, Benito Juárez, C.P. 03100 Ciudad de México, Mexico
Laboratorio de Genómica Humana, Facultad de Medicina, Universidad Veracruzana (UV), Médicos, Unidad del Bosque, Xalapa, C.P. 91010 Veracruz, Mexico
Decanato. Ciencias de la salud. Universidad Autónoma de Guadalajara. Av. Patria 1201, Col. Lomas del Valle, C.P. 45129 Zapopan, Mexico
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(9), 2711;
Received: 7 August 2018 / Revised: 30 August 2018 / Accepted: 4 September 2018 / Published: 11 September 2018
(This article belongs to the Special Issue Molecular Biology and Pathology of Breast Cancer)
Predicting response to systemic treatments in breast cancer (BC) patients is an urgent, yet still unattained health aim. Easily detectable molecules such as long non-coding RNAs (lncRNAs) are the ideal biomarkers when they act as master regulators of many resistance mechanisms, or of mechanisms that are common to more than one treatment. These kinds of markers are pivotal in quasi-personalized treatment selection, and consequently, in improvement of outcome prediction. In order to provide a better approach to understanding development of disease and resistance to treatments, we reviewed current literature searching for lncRNA-associated systemic BC treatments including endocrine therapies, aromatase inhibitors, selective estrogen receptor modulators (SERMs), trastuzumab, paclitaxel, docetaxel, 5-fluorouracil (5-FU), anthracyclines, and cisplatin. We found that the engagement of lncRNAs in resistance is well described, and that lncRNAs such as urotelial carcinoma-associated 1 (UCA1) and regulator of reprogramming (ROR) are indeed involved in multiple resistance mechanisms, which offers tantalizing perspectives for wide usage of lncRNAs as treatment resistance biomarkers. Thus, we propose this work as the foundation for a wide landscape of functions and mechanisms that link more lncRNAs to resistance to current and new treatments in years of research to come. View Full-Text
Keywords: breast cancer; lncRNAs; systemic treatments breast cancer; lncRNAs; systemic treatments
Show Figures

Graphical abstract

MDPI and ACS Style

Campos-Parra, A.D.; López-Urrutia, E.; Orozco Moreno, L.T.; López-Camarillo, C.; Meza-Menchaca, T.; Figueroa González, G.; Bustamante Montes, L.P.; Pérez-Plasencia, C. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer. Int. J. Mol. Sci. 2018, 19, 2711.

AMA Style

Campos-Parra AD, López-Urrutia E, Orozco Moreno LT, López-Camarillo C, Meza-Menchaca T, Figueroa González G, Bustamante Montes LP, Pérez-Plasencia C. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer. International Journal of Molecular Sciences. 2018; 19(9):2711.

Chicago/Turabian Style

Campos-Parra, Alma D., Eduardo López-Urrutia, Luz T. Orozco Moreno, César López-Camarillo, Thuluz Meza-Menchaca, Gabriela Figueroa González, Lilia P. Bustamante Montes, and Carlos Pérez-Plasencia. 2018. "Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer" International Journal of Molecular Sciences 19, no. 9: 2711.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop